These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30747421)

  • 1. The Role of Biomarkers in Psychiatry.
    Lozupone M; La Montagna M; D'Urso F; Daniele A; Greco A; Seripa D; Logroscino G; Bellomo A; Panza F
    Adv Exp Med Biol; 2019; 1118():135-162. PubMed ID: 30747421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.
    Lozupone M; Seripa D; Stella E; La Montagna M; Solfrizzi V; Quaranta N; Veneziani F; Cester A; Sardone R; Bonfiglio C; Giannelli G; Bisceglia P; Bringiotti R; Daniele A; Greco A; Bellomo A; Logroscino G; Panza F
    Expert Rev Proteomics; 2017 Sep; 14(9):809-824. PubMed ID: 28870126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker-Guided Tailored Therapy.
    Lydiard J; Nemeroff CB
    Adv Exp Med Biol; 2019; 1192():199-224. PubMed ID: 31705496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of psychiatric diseases: current status and future prospects.
    Kalia M; Costa E Silva J
    Metabolism; 2015 Mar; 64(3 Suppl 1):S11-5. PubMed ID: 25467847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of biomarkers in psychiatry: focus on proteomics.
    Sokolowska I; Ngounou Wetie AG; Wormwood K; Thome J; Darie CC; Woods AG
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S9-18. PubMed ID: 24357051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can proteomics-based diagnostics aid clinical psychiatry?
    Filiou MD
    Proteomics Clin Appl; 2015 Oct; 9(9-10):885-8. PubMed ID: 25619150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of blood-based protein biomarker strategies in the study of psychiatric disorders.
    Chan MK; Gottschalk MG; Haenisch F; Tomasik J; Ruland T; Rahmoune H; Guest PC; Bahn S
    Prog Neurobiol; 2014 Nov; 122():45-72. PubMed ID: 25173695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future.
    Comes AL; Papiol S; Mueller T; Geyer PE; Mann M; Schulze TG
    Transl Psychiatry; 2018 Aug; 8(1):160. PubMed ID: 30115926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in Psychiatric Disorders.
    Glannon W
    Camb Q Healthc Ethics; 2022 Oct; 31(4):444-452. PubMed ID: 36398503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.
    Patel S
    Expert Rev Proteomics; 2012 Jun; 9(3):249-65. PubMed ID: 22809205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomics for investigating psychiatric disorders.
    Filiou MD; Turck CW; Martins-de-Souza D
    Proteomics Clin Appl; 2011 Feb; 5(1-2):38-49. PubMed ID: 21280236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utility of Multiplex Assays for Identification of Proteomic Signatures in Psychiatry.
    Chen J; Guest PC; Schwarz E
    Adv Exp Med Biol; 2017; 974():131-138. PubMed ID: 28353229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Neuroscience: A Framework for Developing Biomarkers in Psychiatry.
    Lydon-Staley DM; Bassett DS
    Curr Top Behav Neurosci; 2018; 40():79-109. PubMed ID: 29626337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proteomics: biomarker research in psychiatry].
    Hünnerkopf R; Grassl J; Thome J
    Fortschr Neurol Psychiatr; 2007 Oct; 75(10):579-86. PubMed ID: 17566964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion magnetic resonance imaging in psychiatry.
    Théberge J
    Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-psychiatry: an agenda for clinical practice and innovative research.
    Leboyer M; Berk M; Yolken RH; Tamouza R; Kupfer D; Groc L
    BMC Med; 2016 Oct; 14(1):173. PubMed ID: 27788673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted proteomic analysis of cognitive dysfunction in remitted major depressive disorder: Opportunities of multi-omics approaches towards predictive, preventive, and personalized psychiatry.
    Schubert KO; Stacey D; Arentz G; Clark SR; Air T; Hoffmann P; Baune BT
    J Proteomics; 2018 Sep; 188():63-70. PubMed ID: 29474866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review.
    Pinto JV; Moulin TC; Amaral OB
    Neurosci Biobehav Rev; 2017 Dec; 83():97-108. PubMed ID: 28986182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How biomarkers will change psychiatry. Part II: Biomarker selection and potential inflammatory markers of depression.
    Macaluso M; Drevets WC; Preskorn SH
    J Psychiatr Pract; 2012 Jul; 18(4):281-6. PubMed ID: 22805902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.